Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
CA 19-9 is the only established tumor marker in pancreatic cancer (PC); the prognostic role of other serum markers like CEA, CRP, LDH or bilirubin has not yet been defined.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 January 2013
|
| In: |
Journal of cancer research and clinical oncology
Year: 2013, Volume: 139, Issue: 4, Pages: 681-689 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-012-1371-3 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00432-012-1371-3
|
| Author Notes: | Michael Haas, Volker Heinemann, Frank Kullmann, Rüdiger P. Laubender, Christina Klose, Christiane J. Bruns, Stefan Holdenrieder, Dominik P. Modest, Christoph Schulz, Stefan Boeck |
| Summary: | CA 19-9 is the only established tumor marker in pancreatic cancer (PC); the prognostic role of other serum markers like CEA, CRP, LDH or bilirubin has not yet been defined. |
|---|---|
| Item Description: | Gesehen am 10.02.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-012-1371-3 |